Part 1: logistic part for excessive zero (ie., having no SAE) |
Parameter |
Odds Ratio (OR) |
95% Confidence Interval |
p-value |
Age at first donepezil |
0.972 |
(0.929, 1.017) |
0.2181 |
Male vs Female |
1.739 |
(0.711, 4.255) |
0.2256 |
Race/Ethnicity |
Hispanic vs NHW |
0.204 |
(0.079, 0.531) |
0.0011 |
NHB vs NHW |
0.659 |
(0.232, 1.867) |
0.4321 |
Number of donepezil prescription |
0.027 |
(0.003, 0.231) |
0.0010 |
Number of months on donepezil |
0.966 |
(0.834, 1.119) |
0.6448 |
Chronic conditions * (Only p < 0.05 are shown here) |
Anemia |
0.268 |
(0.097, 0.74) |
0.0110 |
Ischemic Heart Disease |
0.122 |
(0.029, 0.52) |
0.0044 |
Part 2: negative binomial part |
Parameter |
Estimate |
95% Confidence Interval |
p-value |
Age at first donepezil |
0.998 |
(0.988, 1.007) |
0.5995 |
Male vs Female |
1.072 |
(0.867, 1.326) |
0.5213 |
Race/Ethnicity |
Hispanic vs NHW |
0.874 |
(0.699, 1.093) |
0.2369 |
NHB vs NHW |
1.285 |
(1.042, 1.584) |
0.0190 |
Number of donepezil prescription |
1.104 |
(1.071, 1.139) |
<.0001 |
Number of months on donepezil |
1.023 |
(1.017, 1.03) |
<.0001 |
Chronic conditions * (Only p < 0.05 are shown here) |
Chronic obstructive pulmonary disease (COPD) |
1.397 |
(1.134, 1.719) |
0.0016 |
Hyperlipidemia |
0.756 |
(0.624, 0.916) |
0.0042 |
Hypertension |
1.517 |
(1.202, 1.914) |
0.0004 |
Anxiety disorder |
1.368 |
(1.115, 1.679) |
0.0027 |